arrow
A

Anton A. Legin

University of Vienna
H指数:19
被引数:1,042

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Selectivity for TP53 signalling drives the mode of action of a highly potent N; O; O-tridentate naphthoquinone-based organo-ruthenium anticancer drug candidate

对TP53信号的选择性驱动了一种高活性N; O; O-三齿萘醌基有机钌抗癌药物候选物的的作用模式

2025-08-040
OA
Interaction with Ribosomal Proteins Accompanies Stress Induction of the Anticancer Metallodrug BOLD-100/KP1339 in the Endoplasmic Reticulum

与核糖体蛋白的相互作用伴随着内质网中抗癌金属药物BOLD-100/KP1339的应激诱导

2021-02-0145
OAAI
Albumin-targeting of an oxaliplatin-releasing platinum(iv) prodrug results in pronounced anticancer activity due to endocytotic drug uptake in vivo

释放奥沙利铂的铂 (iv) 前药的白蛋白靶向由于体内内吞药物吸收而导致显着的抗癌活性

2021-01-0125
OAAI